Where I see patients (2)
My reviews
Selected research
-
Progression of Low-Grade Neuroendocrine Tumors (NET) to High-Grade Neoplasms Harboring the NEC-Like Co-alteration of RB1 and TP53.
Endocrine pathology
-
Updated Survival Follow-Up for Phase Ib Trial of the Histone Deacetylase Inhibitor Abexinostat With Pazopanib in Patients With Solid Tumor Malignancies.
JCO precision oncology
-
Metastatic insulinoma-outcomes in the current era.
The oncologist
Clinical trials
Lenvatinib Plus Pembrolizumab in Well Differentiated G3 Neuroendocrine Tumors
ORR is defined as a complete response (CR) or a partial response (PR) according to RECIST version 1.1 criteria. The All Subjects as Treated (ASaT, ITT) population will be used for analysis which consists of all participants who re...
Recruiting
4.9